Top 5 Indian Stocks to Buy on August 28: Piramal Pharma, Adani Power
By ThePip Desk
Analysts recommend 5 Indian stocks for purchase on August 28, including Piramal Pharma & Adani Power, citing significant upside potential. See targets & stop-losses.
Technical analysts on August 28 recommended five Indian stocks for potential purchase, citing specific target prices and stop-loss levels. The suggested picks include Piramal Pharma, Wockhardt, CG Power and Industrial Solutions, Adani Power, and Delhivery.
Piramal Pharma Leads Recommendations
Deven Mehata, a Technical and Derivatives Analyst at IDBI Capital Markets & Securities, advised buying Piramal Pharma shares. The recommendation outlines a clear entry point and projected gains for traders.
- Buy Piramal Pharma at Rs 214.95
- Stop-loss set at Rs 208
- Target price of Rs 230
- Potential upside: approximately 7%
Wockhardt and CG Power Outlook
Market expert Sachin Janardan Sarvade provided recommendations for two stocks, highlighting substantial potential gains for investors. These include Wockhardt and CG Power and Industrial Solutions, with specific ranges and targets.
- Wockhardt: Buy between Rs 1,940 and Rs 1,962
- Stop-loss: Rs 1,779
- Target price: Rs 2,323
- Potential gains: up to 20%
- CG Power and Industrial Solutions: Buy between Rs 888 and Rs 898
- Stop-loss: Rs 799
- Target price: Rs 1,100
- Potential upside: around 24%
Adani Power and Delhivery Targets
Jigar Shantilal Patel, Senior Manager, Equity Technical Research at Anand Rathi Share and Stock Brokers, detailed buy recommendations for Delhivery and Adani Power. His analysis indicates strong short-term upside based on defined parameters.
- Delhivery: Purchase between Rs 455 and Rs 460
- Stop-loss: Rs 440
- Target price: Rs 500
- Potential upside: 10%
- Adani Power: Buy in the Rs 213 to Rs 216 range
- Stop-loss: Rs 205
- Target price: Rs 232
- Potential upside: nearly 9%
These recommendations are based on technical analysis, providing traders with structured entry and exit points. Investors are advised to consult their financial or investment adviser before making any decisions, as these views are solely from the investment advisers.